Antibiotic resistance in Pseudomonas aeruginosa–Mechanisms, epidemiology and evolution
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …
The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …
The epidemiology of carbapenemases in Latin America and the Caribbean
ABSTRACT Introduction: Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp.
infections are major causes of morbidity and mortality, especially due to the emergence and …
infections are major causes of morbidity and mortality, especially due to the emergence and …
Structural and functional aspects of class A carbapenemases
The fight against infectious diseases is probably one of the greatest public health challenges
faced by our society, especially with the emergence of carbapenem-resistant gram …
faced by our society, especially with the emergence of carbapenem-resistant gram …
Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods
AE Laudy, P Rog, K Smolińska-Król, M Ćmiel… - PloS one, 2017 - journals.plos.org
Knowledge of the prevalence of ESBL enzymes among P. aeruginosa strains compared to
the Enterobacteraiceae family is limited. The phenotypic tests recommended by EUCAST for …
the Enterobacteraiceae family is limited. The phenotypic tests recommended by EUCAST for …
[PDF][PDF] The intriguing carbapenemases of Pseudomonas aeruginosa: Current status, genetic profile, and global epidemiology
DH Halat, CA Moubareck - Yale J. Biol. Med, 2022 - pdfs.semanticscholar.org
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …
difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa …
High prevalence of antimicrobial resistance among gram-negative isolated bacilli in intensive care units at a tertiary-care hospital in Yucatán Mexico
AH Uc-Cachón, C Gracida-Osorno, IG Luna-Chi… - Medicina, 2019 - mdpi.com
Background and Objectives: Antimicrobial resistance (AMR) is increasing worldwide and
imposes significant life-threatening risks to several different populations, especially to those …
imposes significant life-threatening risks to several different populations, especially to those …
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results …
JA Karlowsky, KM Kazmierczak… - Antimicrobial agents …, 2018 - Am Soc Microbiol
The in vitro activities of ceftazidime-avibactam and comparators against 9,149 isolates of
Enterobacteriaceae and 2,038 isolates of Pseudomonas aeruginosa collected by 42 …
Enterobacteriaceae and 2,038 isolates of Pseudomonas aeruginosa collected by 42 …
Antimicrobial resistance in Romania: updates on gram-negative ESCAPE pathogens in the clinical, veterinary, and aquatic sectors
Multidrug-resistant Gram-negative bacteria such as Acinetobacter baumannii,
Pseudomonas aeruginosa, and members of the Enterobacterales order are a challenging …
Pseudomonas aeruginosa, and members of the Enterobacterales order are a challenging …
The collateral effects of COVID-19 pandemic on the status of carbapenemase-producing pathogens
C Ayoub Moubareck… - Frontiers in Cellular and …, 2022 - frontiersin.org
The serious challenge of antimicrobial resistance continues to threaten public health and
lingers in the era of the coronavirus disease 2019 (COVID-19), declared pandemic by the …
lingers in the era of the coronavirus disease 2019 (COVID-19), declared pandemic by the …